- Report
- July 2022
- 298 Pages
Global
From €3378EUR$3,500USD£2,898GBP
- Report
- April 2023
- 116 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- January 2022
- 200 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Report
- January 2022
- 60 Pages
Global
From €3813EUR$3,950USD£3,270GBP
Valtrex is an antiviral drug used to treat infections caused by certain types of viruses, including herpes zoster (shingles), herpes simplex (genital herpes), and varicella zoster (chickenpox). It is also used to treat cold sores and to prevent recurrent outbreaks of genital herpes. Valtrex belongs to a class of drugs known as nucleoside analogues, which work by blocking the replication of viral DNA.
Valtrex is used to treat a variety of infectious diseases, including herpes zoster, herpes simplex, and varicella zoster. It is also used to treat cold sores and to prevent recurrent outbreaks of genital herpes. In addition, Valtrex is used to treat Epstein-Barr virus (EBV) infections, which can cause mononucleosis.
The Valtrex market is a subset of the larger infectious diseases drugs market. It is a competitive market, with a number of companies offering products that are used to treat a variety of viral infections. Companies in the Valtrex market include GlaxoSmithKline, Novartis, Merck, Pfizer, and Sanofi. Show Less Read more